The Time-Dependent Association of Torque Teno Virus Load with the Level of SARS-CoV-2 S1 IgG Antibodies Following COVID-19 Vaccination in Kidney Transplant Recipients

被引:3
作者
Imhof, Celine [1 ]
Messchendorp, Lianne [1 ]
van Baarle, Debbie [2 ]
Gansevoort, Ron T. [1 ]
Van Leer-Buter, Coretta [2 ]
Sanders, Jan-Stephan F. [1 ]
机构
[1] Univ Med Ctr Groningen, Dept Internal Med, Div Nephrol, NL-9713 GZ Groningen, Netherlands
[2] Univ Med Ctr Groningen, Dept Med Microbiol & Infect Prevent, NL-9713 GZ Groningen, Netherlands
来源
VIRUSES-BASEL | 2023年 / 15卷 / 11期
关键词
COVID-19; vaccination; Torque teno virus; kidney transplantation; IMMUNOSUPPRESSION;
D O I
10.3390/v15112189
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Kidney transplant recipients (KTR) show an impaired humoral immune response to COVID-19 vaccination due to their immunocompromised status. Torque teno virus (TTV) is a possible marker of immune function. This marker may be helpful in predicting the immune response after COVID-19 vaccination in order to decide which vaccination strategy should be applied. We therefore investigated whether TTV load is associated with the humoral response after COVID-19 vaccination. Of the KTR who participated in two prospective vaccination studies and received two to four doses of the mRNA-1273 COVID-19 vaccine, 122 were included. TTV load was measured prior to vaccination, and S1 IgG antibody levels were measured 28 days after vaccination. TTV load was independently inversely associated with S1 IgG antibodies after COVID-19 vaccination (B: -2.19 (95% CI: -3.6--0.8), p = 0.002). Interestingly, we found a significant interaction between TTV load and time after transplantation (p = 0.005). When patients were longer after transplantation, TTV load was less predictive for S1 IgG antibody response after vaccination compared to patients that were shorter after transplantation. Our data suggest that TTV load is a good marker in predicting COVID-19 vaccination antibody response and may be helpful in selecting a strategy shortly after transplantation. However, this marker should be handled with caution longer after transplantation.
引用
收藏
页数:11
相关论文
共 25 条
  • [1] Humoral and Cellular Immunity following Five Doses of COVID-19 Vaccines in Solid Organ Transplant Recipients: A Systematic Review and Meta-Analysis
    Alotaibi, Abdulmalik S.
    Shalabi, Heba A.
    Alhifany, Abdullah A.
    Alotaibi, Nouf E.
    Alnuhait, Mohammed A.
    Altheaby, Abdulrahman R.
    Alhazmi, Abdulfattah Y.
    [J]. VACCINES, 2023, 11 (07)
  • [2] Vaccination in patients with kidney failure: lessons from COVID-19
    Babel, Nina
    Hugo, Christian
    Westhoff, Timm H.
    [J]. NATURE REVIEWS NEPHROLOGY, 2022, 18 (11) : 708 - 723
  • [3] Antibody and T Cell Response to SARS-CoV-2 Messenger RNA BNT162b2 Vaccine in Kidney Transplant Recipients and Hemodialysis Patients
    Bertrand, Dominique
    Hamzaoui, Mouad
    Lemee, Veronique
    Lamulle, Julie
    Hanoy, Melanie
    Laurent, Charlotte
    Lebourg, Ludivine
    Etienne, Isabelle
    Lemoine, Mathilde
    Le Roy, Frank
    Nezam, Dorian
    Plantier, Jean-Christophe
    Boyer, Olivier
    Guerrot, Dominique
    Candon, Sophie
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (09): : 2148 - 2153
  • [4] Temporal Response of the Human Virome to Immunosuppression and Antiviral Therapy
    De Vlaminck, Iwijn
    Khush, Kiran K.
    Strehl, Calvin
    Kohli, Bitika
    Luikart, Helen
    Neff, Norma F.
    Okamoto, Jennifer
    Snyder, Thomas M.
    Cornfield, David N.
    Nicolls, Mark R.
    Weill, David
    Bernstein, Daniel
    Valantine, Hannah A.
    Quake, Stephen R.
    [J]. CELL, 2013, 155 (05) : 1178 - 1187
  • [5] Persistence of Antibodies to Severe Acute Respiratory Syndrome Coronavirus 2 in Relation to Symptoms in a Nationwide Prospective Study
    den Hartog, Gerco
    Vos, Eric R. A.
    van den Hoogen, Lotus L.
    van Boven, Michiel
    Schepp, Rutger M.
    Smits, Gaby
    van Vliet, Jeffrey
    Woudstra, Linde
    Wijmenga-Monsuur, Alienke J.
    van Hagen, Cheyenne C. E.
    Sanders, Elisabeth A. M.
    de Melker, Hester E.
    van der Klis, Fiona R. M.
    van Binnendijk, Robert S.
    [J]. CLINICAL INFECTIOUS DISEASES, 2021, 73 (12) : 2155 - 2162
  • [6] SARS-CoV-2 Specific Antibody Detection for Seroepidemiology: A Multiplex Analysis Approach Accounting for Accurate Seroprevalence
    den Hartog, Gerco
    Schepp, Rutger M.
    Kuijer, Marjan
    GeurtsvanKessel, Corine
    van Beek, Josine
    Rots, Nynke
    Koopmans, Marion P. G.
    van der Klis, Fiona R. M.
    van Binnendijk, Robert S.
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2020, 222 (09) : 1452 - 1461
  • [7] Covid-19: Infections climb globally as EG.5 variant gains ground
    Dyer, Owen
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2023, 382 : p1900
  • [8] TTV viral load as a predictor of antibody response to SARS COV-2 vaccination
    Focosi, Daniele
    Baj, Andreina
    Azzi, Lorenzo
    Novazzi, Federica
    Maggi, Fabrizio
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2023, 42 (02) : 143 - 144
  • [9] SARS-CoV-2 variants of concern partially escape humoral but not T- cell responses in COVID-19 convalescent donors and vaccinees
    Geers, Daryl
    Shamier, Marc C.
    Bogers, Susanne
    den Hartog, Gerco
    Gommers, Lennert
    Nieuwkoop, Nella N.
    Schmitz, Katharina S.
    Rijsbergen, Laurine C.
    van Osch, Jolieke A. T.
    Dijkhuizen, Emma
    Smits, Gaby
    Comvalius, Anouskha
    van Mourik, Djenolan
    Caniels, Tom G.
    van Gils, Marit J.
    Sanders, Rogier W.
    Munnink, Bas B. Oude
    Molenkamp, Richard
    de Jager, Herbert J.
    Haagmans, Bart L.
    de Swart, Rik L.
    Koopmans, Marion P. G.
    van Binnendijk, Robert S.
    de Vries, Rory D.
    GeurtsvanKessel, Corine H.
    [J]. SCIENCE IMMUNOLOGY, 2021, 6 (59)
  • [10] Görzer I, 2014, J HEART LUNG TRANSPL, V33, P320, DOI 10.1016/j.healun.2013.12.007